ArticleACS omega2026
Anti-Invasive Peptide-Functionalized Nanotubes for Selective c‑Met Targeting and Metal Chelation.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work describes the development of a sustainable and biocompatible drug delivery system using halloysite nanotubes (HNTs). The goal was to create a material that could both deliver the chemotherapy drug doxorubicin (DOX) and selectively target the tumor cells. The synthesis process was made environmentally friendly by using tetrahydropyran (Thp) as a solvent. The HNTs were first functionalized with an amino group using (3-aminopropyl)-triethoxysilane (APTES), followed by the conjugation of two different peptides, P1 and P2, via EDC coupling. Successful functionalization was confirmed by FTIR spectroscopy, and through thermogravimetric analysis (TGA), we determined the degree of functionalization (%
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.